CIK 0000939767
- Large accelerated filer
EXELIXIS, INC.
Sign in to watch- Ticker
- EXEL
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Jan 1
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 043257395
- Phone
- +1 650-837-7000
- Business address
- 1851 HARBOR BAY PARKWAY, ALAMEDA, CA, 94502
- Former names
- EXELIXIS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-09-30 | Senner Christopher J. EVP and CFO | Grant or award | +32,567 | 424,101 | ||
| 2021-09-30 | Senner Christopher J. EVP and CFO | Shares withheld for taxes | −8,573 | $20.63 | $177K | 415,528 |
| 2021-09-30 | Hessekiel Jeffrey EVP and General Counsel | Grant or award | +28,950 | 658,418 | ||
| 2021-09-30 | Hessekiel Jeffrey EVP and General Counsel | Shares withheld for taxes | −7,593 | $20.63 | $157K | 650,825 |
| 2021-09-30 | Haley Patrick J. EVP, Commercial | Grant or award | +28,950 | 309,944 | ||
| 2021-09-30 | Haley Patrick J. EVP, Commercial | Shares withheld for taxes | −5,416 | $20.63 | $112K | 304,528 |
| 2021-09-30 | Lamb Peter EVP, Scientific Strategy & CSO | Grant or award | +28,950 | 418,417 | ||
| 2021-09-30 | Lamb Peter EVP, Scientific Strategy & CSO | Shares withheld for taxes | −7,177 | $20.63 | $148K | 411,240 |
| 2021-09-21 | Senner Christopher J. EVP and CFO | Exercise or conversion | +90,000 | $3.66 | $329K | 446,591 |
| 2021-09-21 | Senner Christopher J. EVP and CFO | Shares withheld for taxes | −55,057 | $20.33 | $1.1M | 391,534 |
| 2021-09-21 | Senner Christopher J. EVP and CFO | Exercise or conversion · Option (right to buy) | −90,000 | 0 | ||
| 2021-09-16 | Haley Patrick J. EVP, Commercial | Exercise or conversion | +25,000 | $1.70 | $43K | 305,994 |
| 2021-09-16 | Haley Patrick J. EVP, Commercial | Sale | −25,000 | $20.36 | $509K | 280,994 |
| 2021-09-16 | Haley Patrick J. EVP, Commercial | Exercise or conversion · Option (right to buy) | −25,000 | 0 | ||
| 2021-09-15 | Lamb Peter EVP, Scientific Strategy & CSO | Exercise or conversion | +47,500 | $6.21 | $295K | 436,967 |
| 2021-09-15 | Lamb Peter EVP, Scientific Strategy & CSO | Sale | −47,500 | $20.46 | $972K | 389,467 |
| 2021-09-15 | Lamb Peter EVP, Scientific Strategy & CSO | Exercise or conversion · Option (right to buy) | −47,500 | 142,500 | ||
| 2021-08-16 | Lamb Peter EVP, Scientific Strategy & CSO | Exercise or conversion | +55,000 | $1.90 | $105K | 444,467 |
| 2021-08-16 | Lamb Peter EVP, Scientific Strategy & CSO | Sale | −55,000 | $18.44 | $1.0M | 389,467 |
| 2021-08-16 | Lamb Peter EVP, Scientific Strategy & CSO | Exercise or conversion · Option (right to buy) | −55,000 | 0 |
Page 30 of 42 · 836 trades